From €2675EUR$3,024USD£2,337GBP
- Report
- September 2024
- 23 Pages
Denmark
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 23 Pages
Greece
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 23 Pages
Bulgaria
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 25 Pages
Czech Republic
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 26 Pages
Malaysia
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 25 Pages
Hungary
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 24 Pages
Bolivia
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 21 Pages
Croatia
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 23 Pages
Georgia
From €995EUR$1,125USD£869GBP
From €2675EUR$3,024USD£2,337GBP
- Report
- September 2024
- 59 Pages
Angola
From €2150EUR$2,431USD£1,878GBP
- Report
- September 2024
- 86 Pages
Bolivia
From €2675EUR$3,024USD£2,337GBP
- Report
- September 2024
- 84 Pages
Georgia
From €2675EUR$3,024USD£2,337GBP
- Report
- September 2024
- 102 Pages
Hungary
From €2675EUR$3,024USD£2,337GBP
- Report
- September 2024
- 102 Pages
Bulgaria
From €2675EUR$3,024USD£2,337GBP
- Report
- September 2024
- 25 Pages
Hungary
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 28 Pages
United Kingdom
From €995EUR$1,125USD£869GBP
- Report
- September 2024
- 25 Pages
Philippines
From €995EUR$1,125USD£869GBP
From €995EUR$1,125USD£869GBP

Allergic Rhinitis is a condition that affects the nose and is caused by an allergic reaction to certain substances. Over the Counter (OTC) drugs are used to treat the symptoms of Allergic Rhinitis, such as sneezing, runny nose, and itchy eyes. OTC drugs are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. Common active ingredients in OTC drugs for Allergic Rhinitis include antihistamines, decongestants, and corticosteroids. These drugs can be used to reduce inflammation, relieve congestion, and reduce the severity of symptoms.
Some companies in the Allergic Rhinitis Drug market include Johnson & Johnson, GlaxoSmithKline, Novartis, Merck, and Sanofi. Show Less Read more